Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin and Azacitidine for Elderly AML
NCT01093573Phase 2Completed
- Start
- Jul 2009
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midostaurin in acute myeloid leukemia (AML). Started Jul 2009; status: completed.
02
Drugs
midostaurin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01093573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093573.